Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
Protein methylation in cellular proliferation and differentiation: non-histone nuclear methyl acceptor protein(s) during 3'-methyl-4-dimethylaminoazobenzene-induced hepatocarcinogenesis
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 March 1997

Protein methylation in cellular proliferation and differentiation: non-histone nuclear methyl acceptor protein(s) during 3'-methyl-4-dimethylaminoazobenzene-induced hepatocarcinogenesis

  • Moon-Kee Paik1,
  • Yoo-Jeong Han,
  • Jung-Hee Hong,
  • Jung-Sook Kim,
  • Kwang-Sun Suh &
  • …
  • Se-Jin Yoon 

Experimental & Molecular Medicine volume 29, pages 35–43 (1997)Cite this article

  • 722 Accesses

  • 1 Citations

  • Metrics details

Abstract

An accelerating effect of methyl-deficient diet (MDD) on hepatocarcinogenesis and methylation pattern of nuclear protein(s) by S-adenosylmethionine: protein arginine N-methyltransferase (protein methylase I, PM-I) have been studied with 3'-methyl-4-dimethyl- aminoazobenzene(MeDAB)-treated rats. The MDD+MeDAB-fed group produced typical cancer cells in the liver almost two weeks earlier than the control synthetic diet (CSD)+MeDAB-fed group. Protein methylase I (PM-I) activity in the livers of MDD alone fed rats began to increase at around 2 weeks after MDD-feeding, reaching a peak at 4 weeks and declining thereafter. When nuclei isolated either from normal livers or from cholangiocarcinoma cells were incubated with PM-I preparation from normal liver, 16 and 23-kDa nuclear proteins were the major methylated proteins, regardless of the source of the nuclei. However, when the above mentioned nuclei were incubated with PM-I preparations either from MDD alone fed livers or MDD+ MeDAB-induced cholangiocarcinoma cells, the methylation of 23-kDa protein was not detected. The result suggests that there is a hitherto-unknown PM-I specific to 23 kDa nuclear protein which was lost during methyl deficient diet feeding and hepatocarcinogenesis. The N-terminal 20 amino acids sequence of the 23-kDa protein was found to be (1)Gly-Val-Pro-Leu-(5)X-Arg-Leu-Phe-Asp-(10)His-Ala-Met-Leu-Gln-(15)Ala -His-Arg-Ala-His-(20)Glu, having 94.7% sequence homology with human chorionic somatomammotropin precursor A and B.

Similar content being viewed by others

Profiling of RNA N6-Methyladenosine methylation reveals the critical role of m6A in betaine alleviating hepatic steatosis

Article Open access 01 March 2025

Phenethylamine in chlorella alleviates high-fat diet-induced mouse liver damage by regulating generation of methylglyoxal

Article Open access 23 July 2021

LASS2 enhances p53 protein stability and nuclear import to suppress liver cancer progression through interaction with MDM2/MDMX

Article Open access 14 November 2023

Article PDF

Author information

Authors and Affiliations

  1. Department of Biochemistry, School of Medicine, Wonkwang University, Ik-San, Korea

    Moon-Kee Paik

Authors
  1. Moon-Kee Paik
    View author publications

    Search author on:PubMed Google Scholar

  2. Yoo-Jeong Han
    View author publications

    Search author on:PubMed Google Scholar

  3. Jung-Hee Hong
    View author publications

    Search author on:PubMed Google Scholar

  4. Jung-Sook Kim
    View author publications

    Search author on:PubMed Google Scholar

  5. Kwang-Sun Suh
    View author publications

    Search author on:PubMed Google Scholar

  6. Se-Jin Yoon
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Paik, MK., Han, YJ., Hong, JH. et al. Protein methylation in cellular proliferation and differentiation: non-histone nuclear methyl acceptor protein(s) during 3'-methyl-4-dimethylaminoazobenzene-induced hepatocarcinogenesis. Exp Mol Med 29, 35–43 (1997). https://doi.org/10.1038/emm.1997.6

Download citation

  • Published: 01 March 1997

  • Issue date: 01 March 1997

  • DOI: https://doi.org/10.1038/emm.1997.6

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • protein methyltransferases
  • cell division
  • cell differentiation
  • nuclear proteins
  • rat
  • dimethylaminoazobenzene
  • hepatoma
  • carcinogens

This article is cited by

  • Inhibitory effect of arginine-derivatives from ginseng extract and basic amino acids on protein-arginine N-methyltransferase

    • B. C. Yool
    • G. H. Park
    • W. I. Hwang

    Amino Acids (1999)

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited